Seres Therapeutics, Inc. · NASDAQ:MCRB
Shaff Eric D. sold 287 Seres Therapeutics, Inc. shares (Form 4)
Traded Nov 15 to Nov 16, 2026 · Filed Nov 17, 2026
From Nov 15 to Nov 16, 2026, Shaff Eric D. (Director) sold 287 Seres Therapeutics, Inc. shares at US$1.38 for US$396 under a trading plan, leaving 12,936 shares. Filed Nov 17, 2026 (Form 4).
- Sold
- 287 shares
- Price
- US$1.38
- Value
- US$396
- Holding after
- 12,936 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 15, 2026 | Common Stock | Option exercise | 724 | 13,223 | Direct | |
| Nov 16, 2026 | Common Stock | Sale | 287 | US$1.38 | 12,936 | Direct |
Source
Download original · View original at SEC
Related
- Seres Therapeutics, Inc.
- Shaff Eric D.
- Seres Therapeutics, Inc. shareholders
- Form 4 · Shaff Eric D. · Aug 18, 2026
- Form 4 · Shaff Eric D. · May 19, 2026
- Form 4 · Brady Kelly · Nov 17, 2026
- Form 4 · DesRosier Thomas · Nov 17, 2026
- Form 4 · Henn Matthew R · Nov 17, 2026
- Form 4 · Brady Kelly · Aug 18, 2026
- Form 4 · Henn Matthew R · Aug 18, 2026